Gilat Schreiber

Gilat Schreiber has an extensive work experience in various leadership roles. Gilat is currently serving as the Chief Technology Officer at Tel Aviv Medical Center since October 2021. Prior to this, they worked as the General Manager of the Home Infusion Division at Novolog - The Health Care Group from May 2020 to September 2021.

Gilat also has experience with startups. Gilat served as the Chief Product Officer at MyHomeDoc from January 2020 to June 2020, and later became the CEO of the company from September 2016 to January 2020. During their time at MyHomeDoc, they were responsible for business development, R&D, finance, IP, and regulation.

Before joining MyHomeDoc, Gilat worked at EnzySurge as an Engineering and Products Manager from November 2011 to August 2016. Gilat led important projects and was responsible for evaluating new technologies, conducting agronomic tests, and managing user satisfaction.

Prior to that, they worked at Teva Pharmaceuticals as a Portfolio Manager from January 2009 to October 2011. During their time at Teva, they were involved in sourcing new products, conducting market analysis, and creating marketing collateral.

Gilat also has experience as a Project Manager at NanoPass from June 2007 to September 2008, and at Radiancy from May 2004 to July 2007.

Overall, Gilat Schreiber has a diverse background in leadership roles in the medical and pharmaceutical industries.

Gilat Schreiber has a B.Sc in BioMedical Engineering from Ben-Gurion University of the Negev, which they completed from 2001 to 2005. Gilat also holds an MBA in Marketing/Marketing Management, General from the same university, which they obtained from 2008 to 2010.